Intercure (INCR) CFO Amos Cohen Receives 590,000 Option Award

What Happened
Amos Cohen, Chief Financial Officer of Intercure Ltd. (INCR), was granted 590,000 stock options on June 9, 2026. The options are reported as a derivative award (no cash paid on grant). The exercise price is NIS 3.00 per share, converted for this filing to $1.00 per share (see footnote). At that exercise price, exercising all options would require $590,000 in cash. The options were reported as fully vested as of the grant date.

Key Details

• Transaction date: June 9, 2026 (Form 4 filed Aug 24, 2026). The filing was submitted ~76 days after the transaction.
• Grant: 590,000 options (derivative award), acquisition price reported as $0.00.
• Exercise price: NIS 3.00/share, converted using NIS 2.99 = $1.00 to USD for this filing, resulting in $1.00 exercise price per share (footnote F1).
• Vesting: Options became fully vested on June 9, 2026 (per footnote).
• Shares owned after transaction: Not specified in the provided summary; see the full Form 4 for total holdings.
• Filing timeliness: Late filing (filed Aug 24 for a June 9 transaction); late Form 4s reduce near-term transparency for investors.

Context
This transaction is a grant of stock options (an award), not an immediate purchase or sale of underlying shares. Because the options are vested, Cohen can exercise them going forward by paying the exercise price ($1.00/share) unless other arrangements (cashless exercise, net settlement) are used — the filing does not indicate any immediate exercise or sale. Grants and option awards are common executive compensation but do not by themselves indicate immediate market action.